Trial Profile
Proof-of-concept pilot trial: CCP 07 vs immediate-release reference cold/cough product
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 May 2014
Price :
$35
*
At a glance
- Drugs TRN 124 (Primary)
- Indications Common cold; Cough
- Focus Proof of concept; Therapeutic Use
- Sponsors Vernalis
- 06 May 2014 New trial record